Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $5.40, $0.18 better than the analyst estimate of $5.22. Revenue for the quarter came in at $11.45 billion versus the consensus estimate of $10.46 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2023 revenue of $45.3-43.921 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.